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A B S T R A C T
The aim of this investigation was to determine whether H. pylori infection is an independent risk factor for acute myo-
cardial infarction (AMI), determine is there a link between H. pylori infection and severity of disease. In this prospective,
single centre study, were enrolled 100 patients with AMI and control group was consisted 93 healthy individuals. The re-
sults of this study showed no difference between H. pylori seropositivity distribution in the investigate and control group
(29 vs. 26 %) and there was no significant difference on the severity of the disease. There was significant association in
the patients with three and more risk factors, where the patients with lower blood pressure (124.4/77.4 vs. 145.9/87.7
mmHg) and better controled diabetes (HbA1c 6.1 % vs. 6.9 %) had greater risk for AMI if they are H. pylori seropositive.
The large multicentric trials would be needed to define a precise role of H. pylori infection on the developement of AMI.
Key words: Helicobacter pylori infection, acute myocardial infarction
Introduction
There are several studies which showed that chronic
infections may be associated with onset of atherosclero-
sis and subsequently coronary artery disease1,2. H. pylory
infection may couse chronic low grade infection which
lead to production of different vasoactive substances
with direct influence on coagulation system and may
couse prothrombotic status with developement of coro-
nary heart disease (CHD) and onset of acute myocardial
infarction (AMI)3,4. H. pylori infection cuold induce chan-
ges in cogulation with elevated serum levels of fibri-
nogen, prothrombin fragments, plasminogen-activating
inhibitor-1 (PAI-1), and factor VII. Several other macha-
nisms may be responsible for onset of CHD and AMI like
elevated concentrations of tumor necrosis factor- ,
(TNF- ), interleukin-6, (IL-6) and interleukin-8 (IL-8),
lipid profile changes5–8. H. pylori DNA was isolated by
polimerase chain reaction from atherosclerotic plaque
and it is reasonable to purpose direct effect on lession
pregression and activation of inflammation can lead to
acute coronary syndromes9,10. Still, there are contro-
versis about role of H. pylori infection in CHD and AMI,
with many studies pro11–16 and many contra that
association17–21. H. pylori infection is associated with
some socioeconomic factors, particulary low social grade
which can contribute to higher incidence of cardiovascu-
lar diseases. The purpose of this study was to determine
whether H. pylori infection is an indipendent risk factor
for AMI, determine is there a lin between H. pylori infec-
tion and severity of disease, find out is there link be-
tween H. pylori infection and well known risk factors for
CHD and AMI.
Material and Methods
In this prospective study were enrolled 100 patients
admitted in single centre with AMI. All subjects had
given informed consent to inclusion in the study and re-
search was carried out according with principles of Dec-
laration of Helsinki. Control group was consisted of 93
healthy participants. Exclusion criteria were well known
ulcer disease, treatment for ulcer disease in the last 12
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months and eradication therapy for H. pylori in the last
12 months.
Diagnosis for AMI was established in patients with
chest pain in the last 24 hours followed by ECG changes
and elevated heart enzyms: creatine kinaze (CK), its
isoenzyme MB (CK-MB) and troponin I. A 97 of total 100
patients with AMI undergoing cardiac catheterization
and percutane coronary intervention (PCI), coronary
angiograms were read by an expirienced invasive cardiol-
ogists who were blinded to the patients H. pylori status.
Angiograms were graded as normal if there was no af-
fected coronary artery or abnormal. Abnormal angio-
grams were further subdivaded into groups according to
the number of affected vessels in the: single, double or
triple vessel disease.
Analyzed risk factors for CHD included hypertension,
diabetes, hyperlipidemia, obesity, gender and cigarette
smoking. Hypertension was considered in the patients
with arterial pressure >140/90 mmHg, or were being
treated with antihypertensive drugs or dietary modifica-
tions. Diabetic patients were considered to have diabetes
if they have had fasting glucose >6.4 mmol/L, HbA1c>
6.0% or were taking insulin, hypoglicemic agents or di-
etary modification to control the disease. Hyperlipidemia
were considered in patients with serum cholesterol levels
>5.2 mmol/L or receiving lipid lowering agents. Obesity
status was defined followed by body mass index (BMI):
subjects with BMI <24 were considered normal, BMI
25–29 were considered overweight and BMI >30 were
considered obese. Smoking as risk facor were no consid-
ered in patients who had stopped smoking >20 years ago
or who were <30 years of age when they stopped smok-
ing.
All subjects (patients with AMI and control group)
underwent an enzyme-linked Immulite (chemilumines-
cent) analyzer IgG serologic test for H. pylori diagnosis
(Diagnostic Products Corp., Los Angeles, CA, USA). The
test has a sensitivity of 97% and a specificity of 98%.
Control group consists of healthy subjects and they
were excluded if they had history of peptic ulcer disease,
received therapy for eradication H. pylori or received
acid-suppresive drugs in last 12 months.
Statistical analysis is carried out by using SPSS soft-
ware (Statistical Package for the Social Sciences, version
11.0, SPSS Inc., Chicago, IL, USA). For comparing diffe-
rencies between sets of results we used t–tests and for as-
sociations between variables correlation methods. Re-
gression analysis was used for prediction of H. pylori
seropositivity,  2-test was used to find out differencies be-
tween frequency of risk factors. Results are shown by av-
erage values with standard deviations. A value of p<0.05
was considered statistically significant.
Results
Investigate group was consisted of 100 individuals ad-
mitted in coronay care unit for AMI with ST segment ele-
vation (STEMI) or without ST segment elevation (non-
STEMI). Demographic characteristics of patients are
listed in the Table 1.
There were 67 men (67%) and 33 women (33%) with
average age of 64.7 years. There were 77 % hypertensive
patients with average values of 144/88 mmHg, 59% pa-
tients were diabetic and average values od serum glucose
in whole group were 8.6 mmol/L with HbA1c levels of
6.4%. Th whole group were overweight with average BMI
values 27.3 kg/m², there were 67% of patients with
hyperlipidemia and average cholesterol levels in whole
group were 5.8 mmol/L. Smoking as a risk factor was
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TABLE 1
DEMOGRAPHIC CHARACTERISTICS OF PATIENTS
Number X Min Max SD
Age 100 64.74 35.00 87.00 11.34
Gender 100 1.33 1.00 2.00 0.47
Hypertension (grade) 100 1.02 0.00 2.00 0.70
Systolic pressure (mmHg) 100 143.75 80.00 250.00 33.49
Diastolic pressure (mmHg) 100 87.95 50.00 140.00 18.18
Dyslipidemia (yes/no) 100 0.67 0.00 1.00 0.47
Cholesterol (mmol/L) 100 5.77 0.71 8.60 1.30
Glucose (mmol/L) 100 8.59 5.00 22.70 3.79
Diabetes (yes/no) 100 0.41 0.00 1.00 0.49
HbA1c (%) 100 6.37 5.20 11.80 1.32
Body mass index (kg/m²) 100 27.29 20.00 42.00 3.78
Smoking (yes/no) 100 1.50 1.00 2.00 0.50
STEMI/nonSTEMI 100 1.44 1.00 2.00 0.50
Coronary angiography (number of affected vessels) 97 1.82 0.00 3.00 0.94
Troponin I (ng/mL) 100 33.76 0.60 234.20 46.72
H. pylori 100 1.71 1.00 2.00 0.46
present in the 50% of patients. A total of 56 patients
(56%) had STEMI vs. 44 (44%) with nonSTEMI. In 97
pateints with coronary angiography there were 1.8 aver-
age affected coronary arteries. Average troponin levels
were 33.8. Procalcitonin as a marker for infection was in
normal levels in both patients and control group, inde-
pendent of H. pylori seropositivity. There were 29% pa-
tients seropositive for H. pylori versus 26% in control
grouup of healthy individuals and there was no signifi-
cant statistical difference in H. pylori infection between
two groups, also there was no significant differencies be-
tween men and women (30 vs. 27%). When we compare
men and women we find out that women were 5.5 years
younger than men (62.9 vs. 68.4 year) and there were sig-
nificant lower number of women (p=0.001) who had
smoking as a risk factor (27% vs. 61%). There were no
significant diferrences between men and women in dis-
tribution of hypertension, diabetes, obesity, hyperlipide-
mia, STEMI and number of affected coronary vessels.
When we want to find out possible relationship of H.
pylori infection to severity of coronary artery disease, we
found 29% patients with triple vessel disease, 32% with
double vessel disease, 32% with single vessel disease and
7% without significant stenosis of coronary arteries.
There was not significant difference in seroprevalence of
H. pylori infection between patients with no coronary ar-
tery disease, single or triple vessel disease. Only signifi-
cant difference according to the  2-test was noticed in
group of double vessel dissease where there was small
number of seropositive H. pylori patients (only 3 pa-
tients), so that isolated result of double vessel disease is
statisticaly nonconfidential. The results are shown on
Figure 1.
Comparing the results of patients with three and
more risk factors according to the H. pylori seropositivity
we got significant difference in systolic and diastolic
blood pressure (p=0.01, p=0.02), and diabetes (serum
glucose p=0.01, HbA1c p=0.02). The results are shown
in Table 2.
Discussion
Several studies suggested that H. pylori couse low
grade chronic bacterial infection which lead to produc-
tion of different vasoactive substancies linked to the
developement of coronary heart disease. H. pylori infec-
tion may increase risk for acute myocardial infarction
through the changes in the lipid status with lower HDL
cholesterol values and elevated serum trigliceride values,
changes in the coagulation parameters with elevated
fibrinogen, prothrombin fragments, plasminogen-activa-
ting inhibitor 1 (PAI-1) and factor VII, increased concen-
trations of markers of inflammation as a tumor necrosis
factor –  (TNF- ), interleukin-6 (IL-6), interleukin-8
(IL-8) and others. Also it has been noticed possible direct
effect on the stability of the atherosclerotic plaque. Both
H. pylori infection and coronary artery disease are asso-
ciatted with lower socioeconomic status and their fre-
quency is higher with older age8.
Some studies find association of H. pylori infection
and acute coronary syndromes. In those studies there
were reletively high persent of H. pylori seropositivity in
both, patients and controls. Miyazaki et al. in 2006 re-
ported 87.9% H. pylori seropositive patients vs. 66.7% in
control group in Japanese population. In Italian study
from 2003 Pelicano et al. find 81% seropozitive patients
with acute coronary syndrome vs. 53% in control group.
These results were confirmed by another Italian study
performed by Lenzi et al. who find 78.7% H. pylori sero-
positive patients vs. 76% in control group. Whincup et al.
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Fig. 1. Number of affected coronary vessels according to the
H. pylori seropositivity.
TABLE 2
COMPARISON OF PATIENTS WITH H. PYLORI AND 3 RISK FACTORS (RF) WITH THOSE WITHOUT H. PYLORI BUT WITH 3 RF FOR
CORONARY ARTERY DISEASE
3 RF + HP 3 RF – HP t-value df p SD – 1 SD – 2
Syst 124.4000 145.8571 –2.55639 58 0.013217 31.86299 32.18708
Diast 77.4000 87.7143 –2.36242 58 0.021532 17.91880 15.73414
Cholest 5.9160 6.1000 –0.59127 58 0.556640 0.76631 1.41234
Glucose 7.7040 10.4429 –2.45872 58 0.016949 2.46416 5.15588
HbA1c 6.0800 6.9343 –2.35590 58 0.021879 0.77028 1.68888
BMI 28.5200 27.6857 0.91203 58 0.365530 3.28024 3.63619
Cor.ang. 1.6000 1.8788 –1.14147 56 0.258532 1.08012 0.78093
Trop. 27.1520 29.6457 –0.24420 58 0.807934 34.46445 41.90085
in British study from 1996 found 70% seropositive patients
with coronary hearth disease vs. 57% in controls11,12,22,23.
Despite these results in the studies which did not
show association of H. pylori infection and coronary ar-
tery disease there was lower incidence of H. pylori sero-
positivity in patients and controls. Kurshid et al. found
45% seropositive in patients and 47% in controls, Folsom
et al. found 51% H. pylori seropositivity in both groups.
Tsai et al. in Taiwanian study found 69% seropositivity
in investigate vs. 72% in controls4,17,19. In resent Croatian
study performed by V~ev et al. showed higher seropre-
valence of H. pylori infection in patients with coronary
artery disease compared to controls (78.8 vs. 58.3%), but
H. pylori infection was not associated with coronary ar-
tery disease risk factors (smoking, obesity, diabetes, hy-
pertension, cholesterol and socioeconomic status)20.
In our study we found 29% H. pylori seropositive pa-
tients with acute myocardial infarction vs. 26% seroposi-
tive healthy controls. There was not significant statisti-
cal difference (p=0.08) between these groups which
sugest that H. pylori infection is not independent risk
factor for acute myocardial infarction. In our study there
was significantly lower incidence of H. pylory infection in
both patients and controls, particulary due to exclusion
criteria of all participants with known gastric disease, or
receiving therapy for gastric disease or eradication for H.
pylori, particulary for better socioeconomic conditions
compare to postwar period in Croatia in recent studies23.
When we compare these seropositivity results with H.
pylori positivity of 36% according to the Pronto Dry test
in all patients underwent gastroscopy in one year in
same center, there is still low incidence of H. pylory infec-
tion in this mediterranean part of Croatia.
Investigating relationship of H. pylori infaction and
severity of coronary artery disease according to the num-
ber of affected vessels (none, single, double and triple
vessel dissease) we did not found strong association.
Only weak statistical significance was found in subgroup
of double vessel disease, where H. pylori infection was in
favor for patients, but with only three H. pylori seroposi-
tive patients. Similar results reports Kurshid et al. in
prospective study with patients underwent coronary an-
giography. Also Tsai et al. did not find assotiation of H.
pylori infection and severity of coronary artery disease,
even there was higher incidence of triple vesel dissease in
H. pylori seropositive patients4,19.
In the patients with 3 and more risk factors for AMI
(hypertension, diabetes, hyperlipidemia, obesity and
smoking) we found H. pylori infection as an independent
risk factor. Patients with lower blood pressure and better
controlled diabetes have higher risk for myocardial in-
farction if they are H. pylori seropositive. There was sig-
nificant statistical difference (p<0.05) for systolic and di-
astolic blood pressure (124/77 vs. 146/88 mmHg) and
diabetes (serum glucose 7.7 vs. 10.4 mmol/L and HbA1c
6.1 vs. 6.9%) in patients with 3 and more risk factors who
were H. pylori seropositive vs. patients who were not se-
ropositive.
In summary, we can conclude that H. pylori infection
is a primarily localized infection with weak systemic im-
plications. The present results indicate that H. pylori in-
fection is not an independent risk factor for acute myo-
cardial infarction and it is not risk factor for severity of
dissease. But in the patients with three and more well
known risk factors H. pylori infection could have impact
as an independent risk factor for AMI. Further studies
are needed to define a precise role of H. pylori infection
on the developement of acute myocardial infarction and
coronary artery disease.
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INFEKCIJA HELICOBACTER PYLORI I AKUTNI INFARKT MIOKARDA
S A @ E T A K
Cilj ovog istra`ivanja je bio odrediti da li infekcija Helicobacter pylori predstavlja neovisan faktor rizika za akutni
infarkt miokarda, odrediti da li postoji povezanost te`ine infarkta s infekcijom H. pylori. U ovu prospektivnu studiju
provedenu u jednom centru uklju~eno je 100 bolesnika s akutnim infarktom miokarda i 93 zdrava ispitanika u kon-
trolnoj skupini. Rezulati studije nisu pokazali zna~ajnu razliku u distribuciji infekcije H. pylori u ispitanika i kontrolnoj
skupini (29 vs. 26%) i nije na|ena zna~ajna razlika u te`ini bolesti prema seropozitivnosti na H. pylori. Zna~ajna razlika
na|ena je kod bolesnika s tri i vi{e faktora rizika pri ~emu su bolesnici s ni`im krvnim tlakom (124,4/77,4 vs. 145,9/87,7
mmHg) i bolje reguliranim dijabetesom (HbA1c 6,1 vs. 6,9%) imali ve}i rizik za infarkt miokarda ako su H. pylori
seropozitivni. Potrebne su ve}e multicentri~ne studije za odre|ivanje precizne uloge H. pylori infekcije u nastanku
infarkta miokarda.
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